Covid-19 Impact on Global Neuromyelitis Optica Drug Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 24-Apr-2020
No. of pages: 95
Inquire Before Buying

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.

Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.

In the last several years, global market of Neuromyelitis Optica Drug developed with the production growth rate about 4%. In 2015 global capacity of Neuromyelitis Optica Drug is more than 9100 K units.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Neuromyelitis Optica Drug market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Neuromyelitis Optica Drug industry.

Based on our recent survey, we have several different scenarios about the Neuromyelitis Optica Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 34 million in 2019. The market size of Neuromyelitis Optica Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuromyelitis Optica Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuromyelitis Optica Drug market in terms of revenue.

Players, stakeholders, and other participants in the global Neuromyelitis Optica Drug market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Neuromyelitis Optica Drug market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Neuromyelitis Optica Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuromyelitis Optica Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuromyelitis Optica Drug market.

The following players are covered in this report:

- Pfizer

- Fresenius

- Teva

- Sandoz

- Intas

- Gyjtrs

- NANG KUANG

- Tianjin Kingyork

- Baxter

- CSL

- Grifols

- Octapharma

- CBOP

Neuromyelitis Optica Drug Breakdown Data by Type

- Glucocorticoids

- Immunotherapies

- Other

Neuromyelitis Optica Drug Breakdown Data by Application

- Acute attack

- Remission Prophylactic Treatment

Covid-19 Impact on Global Neuromyelitis Optica Drug Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neuromyelitis Optica Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Neuromyelitis Optica Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Glucocorticoids
1.4.3 Immunotherapies
1.4.4 Other
1.5 Market by Application
1.5.1 Global Neuromyelitis Optica Drug Market Share by Application: 2020 VS 2026
1.5.2 Acute attack
1.5.3 Remission Prophylactic Treatment
1.6 Coronavirus Disease 2019 (Covid-19): Neuromyelitis Optica Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Neuromyelitis Optica Drug Industry
1.6.1.1 Neuromyelitis Optica Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Neuromyelitis Optica Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Neuromyelitis Optica Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Neuromyelitis Optica Drug Market Perspective (2015-2026)
2.2 Neuromyelitis Optica Drug Growth Trends by Regions
2.2.1 Neuromyelitis Optica Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuromyelitis Optica Drug Historic Market Share by Regions (2015-2020)
2.2.3 Neuromyelitis Optica Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Neuromyelitis Optica Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Neuromyelitis Optica Drug Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Neuromyelitis Optica Drug Players by Market Size
3.1.1 Global Top Neuromyelitis Optica Drug Players by Revenue (2015-2020)
3.1.2 Global Neuromyelitis Optica Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Neuromyelitis Optica Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neuromyelitis Optica Drug Market Concentration Ratio
3.2.1 Global Neuromyelitis Optica Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neuromyelitis Optica Drug Revenue in 2019
3.3 Neuromyelitis Optica Drug Key Players Head office and Area Served
3.4 Key Players Neuromyelitis Optica Drug Product Solution and Service
3.5 Date of Enter into Neuromyelitis Optica Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Neuromyelitis Optica Drug Historic Market Size by Type (2015-2020)
4.2 Global Neuromyelitis Optica Drug Forecasted Market Size by Type (2021-2026)
5 Neuromyelitis Optica Drug Breakdown Data by Application (2015-2026)
5.1 Global Neuromyelitis Optica Drug Market Size by Application (2015-2020)
5.2 Global Neuromyelitis Optica Drug Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Neuromyelitis Optica Drug Market Size (2015-2020)
6.2 Neuromyelitis Optica Drug Key Players in North America (2019-2020)
6.3 North America Neuromyelitis Optica Drug Market Size by Type (2015-2020)
6.4 North America Neuromyelitis Optica Drug Market Size by Application (2015-2020)
7 Europe
7.1 Europe Neuromyelitis Optica Drug Market Size (2015-2020)
7.2 Neuromyelitis Optica Drug Key Players in Europe (2019-2020)
7.3 Europe Neuromyelitis Optica Drug Market Size by Type (2015-2020)
7.4 Europe Neuromyelitis Optica Drug Market Size by Application (2015-2020)
8 China
8.1 China Neuromyelitis Optica Drug Market Size (2015-2020)
8.2 Neuromyelitis Optica Drug Key Players in China (2019-2020)
8.3 China Neuromyelitis Optica Drug Market Size by Type (2015-2020)
8.4 China Neuromyelitis Optica Drug Market Size by Application (2015-2020)
9 Japan
9.1 Japan Neuromyelitis Optica Drug Market Size (2015-2020)
9.2 Neuromyelitis Optica Drug Key Players in Japan (2019-2020)
9.3 Japan Neuromyelitis Optica Drug Market Size by Type (2015-2020)
9.4 Japan Neuromyelitis Optica Drug Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Neuromyelitis Optica Drug Market Size (2015-2020)
10.2 Neuromyelitis Optica Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neuromyelitis Optica Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Neuromyelitis Optica Drug Market Size by Application (2015-2020)
11 India
11.1 India Neuromyelitis Optica Drug Market Size (2015-2020)
11.2 Neuromyelitis Optica Drug Key Players in India (2019-2020)
11.3 India Neuromyelitis Optica Drug Market Size by Type (2015-2020)
11.4 India Neuromyelitis Optica Drug Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Neuromyelitis Optica Drug Market Size (2015-2020)
12.2 Neuromyelitis Optica Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Neuromyelitis Optica Drug Market Size by Type (2015-2020)
12.4 Central & South America Neuromyelitis Optica Drug Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview and Its Total Revenue
13.1.3 Pfizer Neuromyelitis Optica Drug Introduction
13.1.4 Pfizer Revenue in Neuromyelitis Optica Drug Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Fresenius
13.2.1 Fresenius Company Details
13.2.2 Fresenius Business Overview and Its Total Revenue
13.2.3 Fresenius Neuromyelitis Optica Drug Introduction
13.2.4 Fresenius Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.2.5 Fresenius Recent Development
13.3 Teva
13.3.1 Teva Company Details
13.3.2 Teva Business Overview and Its Total Revenue
13.3.3 Teva Neuromyelitis Optica Drug Introduction
13.3.4 Teva Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.3.5 Teva Recent Development
13.4 Sandoz
13.4.1 Sandoz Company Details
13.4.2 Sandoz Business Overview and Its Total Revenue
13.4.3 Sandoz Neuromyelitis Optica Drug Introduction
13.4.4 Sandoz Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.4.5 Sandoz Recent Development
13.5 Intas
13.5.1 Intas Company Details
13.5.2 Intas Business Overview and Its Total Revenue
13.5.3 Intas Neuromyelitis Optica Drug Introduction
13.5.4 Intas Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.5.5 Intas Recent Development
13.6 Gyjtrs
13.6.1 Gyjtrs Company Details
13.6.2 Gyjtrs Business Overview and Its Total Revenue
13.6.3 Gyjtrs Neuromyelitis Optica Drug Introduction
13.6.4 Gyjtrs Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.6.5 Gyjtrs Recent Development
13.7 NANG KUANG
13.7.1 NANG KUANG Company Details
13.7.2 NANG KUANG Business Overview and Its Total Revenue
13.7.3 NANG KUANG Neuromyelitis Optica Drug Introduction
13.7.4 NANG KUANG Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.7.5 NANG KUANG Recent Development
13.8 Tianjin Kingyork
13.8.1 Tianjin Kingyork Company Details
13.8.2 Tianjin Kingyork Business Overview and Its Total Revenue
13.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Introduction
13.8.4 Tianjin Kingyork Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.8.5 Tianjin Kingyork Recent Development
13.9 Baxter
13.9.1 Baxter Company Details
13.9.2 Baxter Business Overview and Its Total Revenue
13.9.3 Baxter Neuromyelitis Optica Drug Introduction
13.9.4 Baxter Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.9.5 Baxter Recent Development
13.10 CSL
13.10.1 CSL Company Details
13.10.2 CSL Business Overview and Its Total Revenue
13.10.3 CSL Neuromyelitis Optica Drug Introduction
13.10.4 CSL Revenue in Neuromyelitis Optica Drug Business (2015-2020)
13.10.5 CSL Recent Development
13.11 Grifols
10.11.1 Grifols Company Details
10.11.2 Grifols Business Overview and Its Total Revenue
10.11.3 Grifols Neuromyelitis Optica Drug Introduction
10.11.4 Grifols Revenue in Neuromyelitis Optica Drug Business (2015-2020)
10.11.5 Grifols Recent Development
13.12 Octapharma
10.12.1 Octapharma Company Details
10.12.2 Octapharma Business Overview and Its Total Revenue
10.12.3 Octapharma Neuromyelitis Optica Drug Introduction
10.12.4 Octapharma Revenue in Neuromyelitis Optica Drug Business (2015-2020)
10.12.5 Octapharma Recent Development
13.13 CBOP
10.13.1 CBOP Company Details
10.13.2 CBOP Business Overview and Its Total Revenue
10.13.3 CBOP Neuromyelitis Optica Drug Introduction
10.13.4 CBOP Revenue in Neuromyelitis Optica Drug Business (2015-2020)
10.13.5 CBOP Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Neuromyelitis Optica Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Neuromyelitis Optica Drug Revenue
Table 3. Ranking of Global Top Neuromyelitis Optica Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neuromyelitis Optica Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Glucocorticoids
Table 6. Key Players of Immunotherapies
Table 7. Key Players of Other
Table 8. COVID-19 Impact Global Market: (Four Neuromyelitis Optica Drug Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Neuromyelitis Optica Drug Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Neuromyelitis Optica Drug Players to Combat Covid-19 Impact
Table 13. Global Neuromyelitis Optica Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Neuromyelitis Optica Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Neuromyelitis Optica Drug Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Neuromyelitis Optica Drug Market Share by Regions (2015-2020)
Table 17. Global Neuromyelitis Optica Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Neuromyelitis Optica Drug Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Neuromyelitis Optica Drug Market Growth Strategy
Table 23. Main Points Interviewed from Key Neuromyelitis Optica Drug Players
Table 24. Global Neuromyelitis Optica Drug Revenue by Players (2015-2020) (Million US$)
Table 25. Global Neuromyelitis Optica Drug Market Share by Players (2015-2020)
Table 26. Global Top Neuromyelitis Optica Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromyelitis Optica Drug as of 2019)
Table 27. Global Neuromyelitis Optica Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Neuromyelitis Optica Drug Product Solution and Service
Table 30. Date of Enter into Neuromyelitis Optica Drug Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Neuromyelitis Optica Drug Market Size by Type (2015-2020) (Million US$)
Table 33. Global Neuromyelitis Optica Drug Market Size Share by Type (2015-2020)
Table 34. Global Neuromyelitis Optica Drug Revenue Market Share by Type (2021-2026)
Table 35. Global Neuromyelitis Optica Drug Market Size Share by Application (2015-2020)
Table 36. Global Neuromyelitis Optica Drug Market Size by Application (2015-2020) (Million US$)
Table 37. Global Neuromyelitis Optica Drug Market Size Share by Application (2021-2026)
Table 38. North America Key Players Neuromyelitis Optica Drug Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Neuromyelitis Optica Drug Market Share (2019-2020)
Table 40. North America Neuromyelitis Optica Drug Market Size by Type (2015-2020) (Million US$)
Table 41. North America Neuromyelitis Optica Drug Market Share by Type (2015-2020)
Table 42. North America Neuromyelitis Optica Drug Market Size by Application (2015-2020) (Million US$)
Table 43. North America Neuromyelitis Optica Drug Market Share by Application (2015-2020)
Table 44. Europe Key Players Neuromyelitis Optica Drug Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Neuromyelitis Optica Drug Market Share (2019-2020)
Table 46. Europe Neuromyelitis Optica Drug Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Neuromyelitis Optica Drug Market Share by Type (2015-2020)
Table 48. Europe Neuromyelitis Optica Drug Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Neuromyelitis Optica Drug Market Share by Application (2015-2020)
Table 50. China Key Players Neuromyelitis Optica Drug Revenue (2019-2020) (Million US$)
Table 51. China Key Players Neuromyelitis Optica Drug Market Share (2019-2020)
Table 52. China Neuromyelitis Optica Drug Market Size by Type (2015-2020) (Million US$)
Table 53. China Neuromyelitis Optica Drug Market Share by Type (2015-2020)
Table 54. China Neuromyelitis Optica Drug Market Size by Application (2015-2020) (Million US$)
Table 55. China Neuromyelitis Optica Drug Market Share by Application (2015-2020)
Table 56. Japan Key Players Neuromyelitis Optica Drug Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Neuromyelitis Optica Drug Market Share (2019-2020)
Table 58. Japan Neuromyelitis Optica Drug Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Neuromyelitis Optica Drug Market Share by Type (2015-2020)
Table 60. Japan Neuromyelitis Optica Drug Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Neuromyelitis Optica Drug Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Neuromyelitis Optica Drug Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Neuromyelitis Optica Drug Market Share (2019-2020)
Table 64. Southeast Asia Neuromyelitis Optica Drug Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Neuromyelitis Optica Drug Market Share by Type (2015-2020)
Table 66. Southeast Asia Neuromyelitis Optica Drug Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Neuromyelitis Optica Drug Market Share by Application (2015-2020)
Table 68. India Key Players Neuromyelitis Optica Drug Revenue (2019-2020) (Million US$)
Table 69. India Key Players Neuromyelitis Optica Drug Market Share (2019-2020)
Table 70. India Neuromyelitis Optica Drug Market Size by Type (2015-2020) (Million US$)
Table 71. India Neuromyelitis Optica Drug Market Share by Type (2015-2020)
Table 72. India Neuromyelitis Optica Drug Market Size by Application (2015-2020) (Million US$)
Table 73. India Neuromyelitis Optica Drug Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Neuromyelitis Optica Drug Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Neuromyelitis Optica Drug Market Share (2019-2020)
Table 76. Central & South America Neuromyelitis Optica Drug Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Neuromyelitis Optica Drug Market Share by Type (2015-2020)
Table 78. Central & South America Neuromyelitis Optica Drug Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Neuromyelitis Optica Drug Market Share by Application (2015-2020)
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Fresenius Company Details
Table 86. Fresenius Business Overview
Table 87. Fresenius Product
Table 88. Fresenius Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 89. Fresenius Recent Development
Table 90. Teva Company Details
Table 91. Teva Business Overview
Table 92. Teva Product
Table 93. Teva Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 94. Teva Recent Development
Table 95. Sandoz Company Details
Table 96. Sandoz Business Overview
Table 97. Sandoz Product
Table 98. Sandoz Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 99. Sandoz Recent Development
Table 100. Intas Company Details
Table 101. Intas Business Overview
Table 102. Intas Product
Table 103. Intas Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 104. Intas Recent Development
Table 105. Gyjtrs Company Details
Table 106. Gyjtrs Business Overview
Table 107. Gyjtrs Product
Table 108. Gyjtrs Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 109. Gyjtrs Recent Development
Table 110. NANG KUANG Company Details
Table 111. NANG KUANG Business Overview
Table 112. NANG KUANG Product
Table 113. NANG KUANG Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 114. NANG KUANG Recent Development
Table 115. Tianjin Kingyork Business Overview
Table 116. Tianjin Kingyork Product
Table 117. Tianjin Kingyork Company Details
Table 118. Tianjin Kingyork Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 119. Tianjin Kingyork Recent Development
Table 120. Baxter Company Details
Table 121. Baxter Business Overview
Table 122. Baxter Product
Table 123. Baxter Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 124. Baxter Recent Development
Table 125. CSL Company Details
Table 126. CSL Business Overview
Table 127. CSL Product
Table 128. CSL Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 129. CSL Recent Development
Table 130. Grifols Company Details
Table 131. Grifols Business Overview
Table 132. Grifols Product
Table 133. Grifols Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 134. Grifols Recent Development
Table 135. Octapharma Company Details
Table 136. Octapharma Business Overview
Table 137. Octapharma Product
Table 138. Octapharma Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 139. Octapharma Recent Development
Table 140. CBOP Company Details
Table 141. CBOP Business Overview
Table 142. CBOP Product
Table 143. CBOP Revenue in Neuromyelitis Optica Drug Business (2015-2020) (Million US$)
Table 144. CBOP Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromyelitis Optica Drug Market Share by Type: 2020 VS 2026
Figure 2. Glucocorticoids Features
Figure 3. Immunotherapies Features
Figure 4. Other Features
Figure 5. Global Neuromyelitis Optica Drug Market Share by Application: 2020 VS 2026
Figure 6. Acute attack Case Studies
Figure 7. Remission Prophylactic Treatment Case Studies
Figure 8. Neuromyelitis Optica Drug Report Years Considered
Figure 9. Global Neuromyelitis Optica Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Neuromyelitis Optica Drug Market Share by Regions: 2020 VS 2026
Figure 11. Global Neuromyelitis Optica Drug Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Neuromyelitis Optica Drug Market Share by Players in 2019
Figure 14. Global Top Neuromyelitis Optica Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromyelitis Optica Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Neuromyelitis Optica Drug Revenue in 2019
Figure 16. North America Neuromyelitis Optica Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Neuromyelitis Optica Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Neuromyelitis Optica Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Neuromyelitis Optica Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Neuromyelitis Optica Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Neuromyelitis Optica Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Neuromyelitis Optica Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 25. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Fresenius Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 27. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Teva Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 29. Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Sandoz Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 31. Intas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Intas Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 33. Gyjtrs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Gyjtrs Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 35. NANG KUANG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. NANG KUANG Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 37. Tianjin Kingyork Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Tianjin Kingyork Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 39. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Baxter Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 41. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. CSL Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 43. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Grifols Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 45. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Octapharma Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 47. CBOP Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. CBOP Revenue Growth Rate in Neuromyelitis Optica Drug Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
  • COVID-19 Impact on Global Migraine Drugs, Market Insights and Forecast to 2026
    Published: 30-Jun-2020        Price: US 3900 Onwards        Pages: 151
    Migraine Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Migraine Drugs market is segmented into - Sumatriptan - Zolmitriptan - Rizatriptan - Others ......
  • 2014-2029 Report on Global Narcolepsy Drug Market by Player, Region, Type, Application and Sales Channel
    Published: 30-Jun-2020        Price: US 2500 Onwards        Pages: 134
    The global Narcolepsy Drug market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry......
  • COVID-19 Outbreak-Global Migraine Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 30-Jun-2020        Price: US 3660 Onwards        Pages: 105
    Migraine drugs are used to treat migraine. A migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. Typically, the headaches affect one half of the head, are pulsating in nature, and last from two to 72 hours. The Migraine Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of an......
  • Edaravone Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 26-Jun-2020        Price: US 2280 Onwards        Pages: 55
    Summary According to 99Strategy, the Global Edaravone Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Edaravone market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors ......
  • COVID-19 Outbreak-Global Butadiene Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
    Published: 16-Jun-2020        Price: US 3660 Onwards        Pages: 127
    Butadiene, an organic compound, is obtained as a by-product during the production of ethylene and propylene. Conventionally, butadiene was produced through steam cracking of naphtha followed by extractive distillation. Dehydrogenation of butane or ethanol is also one of the processes used for producing butadiene. On account of high cost involved in producing butadiene by conventional methods and recent discoveries shale gas, especially in the United States, producers are shifting to using lighte......
  • Ethoxyquin Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 11-Jun-2020        Price: US 2280 Onwards        Pages: 44
    Summary According to 99Strategy, the Global Ethoxyquin Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Ethoxyquin market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factor......
  • Neuromyelitis Optica Drug Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)
    Published: 06-Jun-2020        Price: US 2280 Onwards        Pages: 76
    Summary According to 99Strategy, the Global Neuromyelitis Optica Drug Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Neuromyelitis Optica Drug market, the market size and growth, as well as the major market participants. The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, ......
  • 2015-2027 Global Edaravone Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 02-Jun-2020        Price: US 2960 Onwards        Pages: 127
    The worldwide market for Edaravone is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors,......
  • 2015-2027 Global Ethoxyquin Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
    Published: 02-Jun-2020        Price: US 2960 Onwards        Pages: 138
    The worldwide market for Ethoxyquin is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020. The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs